Mario Gabelli Laboratory Corp Of America Holdings Transaction History

Gamco Investors, Inc. Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$167.03 - $201.3 $835,150 - $1.01 Million	-5,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$113.31 - $182.44 $1.02 Million - $1.64 Million	-9,000 Reduced 64.29%	5,000 $831,000
Q1 2020 May 14, 2020	BUY	$104.32 - $195.28 $52,160 - $97,640	500 Added 3.7%	14,000 $1.77 Million
Q3 2019 Nov 01, 2019	SELL	$159.77 - $178.1 $63,908 - $71,240	-400 Reduced 2.88%	13,500 $2.27 Million
Q2 2019 Aug 02, 2019	BUY	$144.16 - $172.9 $1.01 Million - $1.21 Million	7,000 Added 101.45%	13,900 $2.4 Million

Q4 2018 Jan 30, 2019	SELL	$120.82 - $174.09 $120,820 - $174,090	-1,000 Reduced 12.66%	6,900 $872,000
Q3 2018 Nov 02, 2018	BUY	$167.67 - $188.27 $419,174 - $470,675	2,500 Added 46.3%	7,900 $1.37 Million
Q2 2018 Aug 10, 2018	SELL	$160.33 - $189.41 $160,330 - $189,410	-1,000 Reduced 15.63%	5,400 $969,000
Q4 2017 Feb 02, 2018	BUY	$147.99 - $163.95 $443,970 - $491,849	3,000 Added 88.24%	6,400 $1.02 Million
Q3 2017 Nov 01, 2017	BUY	$149.47 - $160.56 $508,198 - $545,904	3,400	3,400 $513,000

1,003

76.8M

265K

192K

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $18.2B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.